a16z Capital Management, L.L.C.
Position in DMRA — Damora Therapeutics, Inc.
CIK 1540358
MENLO PARK, CA
Position in DMRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$32,016,466
New position
Shares Held
1,236,157
first reported quarter
Ownership
2.01%
of shares outstanding
% of Portfolio
2.48%
of 13F equity value
Holder Rank
#14
of 65 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026a16z Capital Management, L.L.C. holds $304,679,821 across 8 Biotechnology names. DMRA ranks #5 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
921,099 | $89,576,877 | |
| 2 | NAUT |
Nautilus Biotechnology, Inc.
|
17,653,917 | $68,497,197 | |
| 3 | MAZE |
Maze Therapeutics, Inc.
|
1,702,225 | $50,811,416 | |
| 4 | ERAS |
Erasca, Inc.
|
2,862,500 | $46,315,250 | |
| 5 | DMRA |
Damora Therapeutics, Inc.
This page
|
1,236,157 | $32,016,466 | |
| 6 | CAMP |
Camp4 Therapeutics Corp
|
2,125,339 | $9,372,744 | |
| 7 | AKTS |
Aktis Oncology, Inc.
|
415,000 | $7,424,350 | |
| 8 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
108,568 | $665,521 |
All Filings in DMRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $32,016,466 | 1,236,157 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||